Purchase Order 75N93022P00800
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The $249,519.59 contract is for a service agreement to provide multiple Illumina DNA sequencers over a 1-year period from August 28, 2025 to August 27, 2026. The contract does not utilize a set-aside designation. Illumina is a...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- This is a $68,929.06 firm fixed price delivery order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is for the provision of various Illumina sequencing systems, reagents, consumables, and support services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contract and subcontract awards from...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for high-throughput DNA sequencing instrument maintenance services, with a base period plus four option years, for a total potential value of $146,277. The contract does not utilize any small business set-aside provisions. Illumina is a manufacturer of genetic analysis instruments...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $52,300 award is for the provision of a Genome Analyzer instrument and related service agreement, with a period of performance ending on April 10, 2015. There was no set-aside designation for this contract. Illumina has a history of providing...
- This $20,641.23 firm fixed price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract provides Illumina reagents and consumables to support the agency's genomic research and analysis work. Illumina has a history of providing sequencing equipment and related products and services to various federal agencies, including...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $190,561.89 contract is for Illumina's sequencing services and is not set-aside. Illumina has provided similar sequencing goods and services to support research and diagnostics for various federal...
- This is a firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for $15,564.92. The contract provides Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. No set-aside designation was used. Illumina has previously received prime contract awards from agencies like the...
This is a $189,332.15 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis instruments and reagents. The contract provides an annual service agreement for four Illumina sequencing instruments, including preventative maintenance, parts, labor, reagent replacement, and technical support. The service period is from July 5, 2022 to July 4, 2023. The contract was competitively awarded without a set-aside. Illumina has a history of providing sequencing systems and services to support genomics research and diagnostics across federal agencies like NIH, CDC, USDA, and VA.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
One year service contract for four (4) Illumina Instruments | RFQ-NIAID-2126122 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 6/16/22, 2:12 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $189.3k | 6/29/22 |